What are Exelixis's total assets?

Exelixis (EXEL) holds $2.6B in total assets, down 8.6% year over year.

How much debt does Exelixis have?

Exelixis carries $169.5M in total debt against $1.9B of shareholders' equity, a debt-to-equity ratio of 0.09.

How much cash does Exelixis have?

Exelixis holds $226.2M in cash and equivalents.

Can Exelixis cover its short-term obligations?

Its current ratio is 3.26 — current assets exceed current liabilities.

Where does Exelixis's balance sheet data come from?

Every line is extracted from Exelixis's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Exelixis EXEL Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$482.49M+122%	$217.37M-17.3%	$262.99M-47.7%	$502.68M-24.3%
Short-term investments	$576.6M-35.5%	$893.9M+22.1%	$732.31M-9.3%	$807.27M-1.5%
Accounts receivable, net	$286.92M+8.1%	$265.44M+11.8%	$237.41M+10.5%	$214.78M-24.0%
Inventories	$60.37M-15.8%	$71.73M-6.0%	$76.32M+22.5%	$62.28M+25.8%
Raw materials	$894K-67.9%	$2.78M-61.9%	$7.31M-9.5%	$8.08M-8.9%
Work in process	$53.53M-11.2%	$60.32M+1.5%	$59.42M+36.4%	$43.56M+57.2%
Finished goods	$5.94M-31.1%	$8.63M-9.9%	$9.58M-9.9%	$10.64M-17.7%
Prepaid expenses and other current assets	$75.6M+10.4%	$68.48M+0.8%	$67.93M+9.2%	$62.21M+8.1%
Trading assets	$691.41M-22.2%	$888.36M+15.6%	$768.71M-31.1%	$1.11B-4.6%
Total current assets	$1.44B-1.7%	$1.47B+11.4%	$1.32B-18.6%	$1.62B-11.8%
Property and equipment, net	$98.96M-17.1%	$119.39M-7.3%	$128.73M+16.4%	$110.62M+6.3%
Goodwill	$63.68M0.0%	$63.68M0.0%	$63.68M0.0%	$63.68M0.0%
Other non-current assets	$0—	——	——	——
Available-for-sale securities	$600.43M-5.8%	$637.29M-12.5%	$728.72M-3.3%	$753.73M+106%
Allowance for credit losses	——	——	——	——
Total assets	$2.84B-3.5%	$2.95B+0.2%	$2.94B-4.2%	$3.07B+17.4%
Accounts payable	$29.62M-22.4%	$38.19M+13.1%	$33.77M+3.4%	$32.67M+34.7%
Accrued expenses	$125.38M+32.0%	$95.01M-12.4%	$108.42M+37.4%	$78.92M+47.9%
Accrued compensation	$102.22M-6.9%	$109.83M+17.7%	$93.33M+21.0%	$77.16M+24.5%
Deferred revenue	$1.12M-59.3%	$2.74M-49.3%	$5.41M-27.8%	$7.49M-4.2%
Contract liabilities	$6.11M+80.2%	$3.39M-38.6%	$5.52M-16.1%	$6.58M-24.7%
Accrued interest	$12.4M-16.8%	$14.9M+13.7%	$13.1M+79.5%	$7.3M+152%
Total current liabilities	$405.64M+0.5%	$403.77M+2.4%	$394.28M+21.6%	$324.36M-3.9%
Operating lease liabilities, non-current	$173.04M-9.3%	$190.82M+0.5%	$189.94M-0.1%	$190.17M+271%
Other non-current liabilities	$104.42M-4.1%	$108.9M+15.6%	$94.22M+37.5%	$68.53M+754%
Total liabilities	$683.1M-2.9%	$703.49M+3.7%	$678.45M+16.4%	$583.06M+43.7%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	400M+141,744%	282K-6.9%	303K-6.5%	324K+1.6%
Additional paid-in capital	$2.23B-4.7%	$2.34B-4.0%	$2.44B-3.8%	$2.54B+4.5%
Retained earnings	-$76.83M+22.1%	-$98.65M+43.1%	-$173.35M-407%	-$34.23M+84.2%
Accumulated other comprehensive income (loss)	$3.48M+358%	-$1.35M+64.1%	-$3.75M+74.2%	-$14.52M-1,816%
Total stockholders' equity	$2.16B-3.7%	$2.24B-0.9%	$2.26B-9.0%	$2.49B+12.6%
Total liabilities and stockholders' equity	$2.84B-3.5%	$2.95B+0.2%	$2.94B-4.2%	$3.07B+17.4%
Available-for-Sale Debt Securities - Amortized Cost	$1.29B-15.7%	$1.53B+1.7%	$1.5B-20.4%	$1.89B+23.0%
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	$10.1M-95.4%	$217.87M-50.8%	$443.24M+86.5%	$237.6M—
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	$10.1M-95.4%	$217.87M-50.8%	$443.24M+86.5%	$237.6M—
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$58.2M-88.2%	$495.29M+18.1%	$419.3M—	——
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	$58.2M-88.2%	$495.29M+18.1%	$419.3M—	——
Available-for-Sale Debt Securities - Unrealized Loss Position	$38K-98.8%	$3.13M-52.5%	$6.58M-65.5%	$19.03M+1,000%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	$10.1M-95.4%	$217.87M-50.8%	$443.24M+86.5%	$237.6M—
AFS and Trading Securities - Unrealized Loss Position Fair Value	$68.3M-90.4%	$713.16M-17.3%	$862.54M-16.3%	$1.03B+127%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$58.2M-88.2%	$495.29M+18.1%	$419.3M—	——
Cash, Cash Equivalents, and Marketable Securities	$68.3M-90.4%	$713.16M-17.3%	$862.54M-16.3%	$1.03B+127%
Short- term Investments	$576.6M-35.5%	$893.9M+22.1%	$732.31M—	——
Available-for-Sale Securities (Non-Current)	$603.6M-5.3%	$637.29M-12.5%	$728.72M—	——
Contract Assets, Non-Current	$0—	——	——	——
Investments - Amortized Cost Basis	$1.29B-15.7%	$1.53B+1.7%	$1.5B-20.4%	$1.89B+23.0%
Deferred tax assets	$292.58M-30.3%	$420.03M+16.3%	$361.15M+56.3%	$231.11M+107%
Long- term Investments	$603.6M-5.3%	$637.29M-12.5%	$728.72M—	——
Operating Lease, Right-Of-Use Asset And Other Non-Current Assets	$342.31M+42.8%	$239.72M-29.9%	$342.12M—	——
Accrued Progress Collections and Price Adjustments	$6.11M+80.2%	$3.39M-38.6%	$5.52M-16.1%	$6.58M-24.7%
Contract Liabilities and Refund Liability	$59.9M-4.0%	$62.38M+4.6%	$59.62M+18.4%	$50.35M+49.4%
Accrued clinical trial liabilities	$65.74M+13.4%	$57.98M-19.0%	$71.62M+10.1%	$65.07M-16.1%
Accrued collaboration liabilities	$22.78M-43.6%	$40.38M+46.7%	$27.53M+36.4%	$20.19M-76.7%
Other accrued liabilities	$125.38M+32.0%	$95.01M-12.4%	$108.42M+37.4%	$78.92M+47.9%
Contract Liabilities, Non-Current	$6.11M+80.2%	$3.39M-38.6%	$5.52M-16.1%	$6.58M-24.7%
Deferred revenue, net of current portion	$6.11M+80.2%	$3.39M-38.6%	$5.52M-16.1%	$6.58M-24.7%
Total debt	$200.92M-6.9%	$215.83M+0.1%	$215.66M+3.8%	$207.83M+268%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	$8K-98.9%	$741K-86.1%	$5.32M-12.7%	$6.1M—
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	262.5M-6.8%	281.7M-7.0%	302.8M-6.5%	324M+1.6%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$262K-7.1%	$282K-6.9%	$303K-6.5%	$324K+1.6%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Investments - Gross Unrealized Losses	$68.3M-90.4%	$713.16M-17.3%	$862.54M-16.3%	$1.03B+127%
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	——	——	——	——
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——
Unrealized Gains on Investments	$4.89M+182%	$1.74M-16.4%	$2.08M+252%	$589K-36.9%
Unrealized Losses on Investments (Before Tax)	$38K-98.8%	$3.13M-52.5%	$6.58M-65.5%	$19.03M+1,000%
Components	35-86.3%	255+10.9%	230-19.3%	285+114%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$38K-98.8%	$3.13M-52.5%	$6.58M-65.5%	$19.03M+1,000%
Gross Unrealized Gains	$4.89M+182%	$1.74M-16.4%	$2.08M+252%	$589K-36.9%
Total	$1.29B-15.7%	$1.53B+1.7%	$1.5B-20.4%	$1.89B+23.0%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	$600.43M-5.8%	$637.29M-12.5%	$728.72M-3.3%	$753.73M+106%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	$691.41M-22.2%	$888.36M+15.6%	$768.71M-31.1%	$1.11B-4.6%
Available for sale investments	$1.29B-15.3%	$1.53B+1.9%	$1.5B-19.9%	$1.87B+21.8%
Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost Basis	$1.66B-5.3%	$1.75B+1.2%	$1.73B-17.1%	$2.09B+12.4%
Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Available For Sale, Debt Securities, Accumulated Gross Unrealized Loss, Before Tax	$38K-98.8%	$3.13M-52.5%	$6.58M-65.5%	$19.03M+1,000%
Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax	$4.89M+182%	$1.74M-16.4%	$2.08M+252%	$589K-36.9%
Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Available-For-Sale, Debt Securities	$1.66B-4.9%	$1.75B+1.4%	$1.72B-16.6%	$2.07B+11.4%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$400M0.0%	$400M0.0%	$400M0.0%	$400M0.0%
Common stock, shares issued (in shares)	$262.48M-6.8%	$281.73M-7.0%	$302.79M-6.5%	$323.95M+1.6%
Common Stock, Shares, Outstanding	$262.48M-6.8%	$281.73M-7.0%	$302.79M-6.5%	$323.95M+1.6%
Contract with Customer, Liability	$7.23M+17.9%	$6.13M-43.9%	$10.93M-22.3%	$14.07M-15.0%
Estimated rate refund liabilities	$59.9M-4.0%	$62.38M+4.6%	$59.62M+18.4%	$50.35M+49.4%
Debt Securities, Available-for-Sale, Allowance for Credit Loss	——	——	——	——
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	$8K-98.9%	$741K-86.1%	$5.32M-12.7%	$6.1M—
Less than 12 months	$58.2M-88.2%	$495.29M+18.1%	$419.3M—	——
12 months or more	$10.1M-95.4%	$217.87M-50.8%	$443.24M+86.5%	$237.6M—
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	$30K-98.7%	$2.39M+90.3%	$1.25M—	——
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss	$38K-98.8%	$3.13M-52.5%	$6.58M-65.5%	$19.03M+1,000%
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions	$35-86.3%	$255+10.9%	$230-19.3%	$285+114%
Debt Securities, Available-for-Sale, Unrealized Loss Position	$68.3M-90.4%	$713.16M-17.3%	$862.54M-16.3%	$1.03B+127%
Cost not yet recognized	——	——	——	——
Raw materials	$894K-67.9%	$2.78M-61.9%	$7.31M-9.5%	$8.08M-8.9%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	——	——	——	——
Valuation Allowances And Reserves Balance	$94.12M+7.4%	$87.64M+3.3%	$84.84M+9.9%	$77.23M+59.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Exelixis.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Exelixis's total assets?: Exelixis (EXEL) holds $2.6B in total assets, down 8.6% year over year.
How much debt does Exelixis have?: Exelixis carries $169.5M in total debt against $1.9B of shareholders' equity, a debt-to-equity ratio of 0.09.
How much cash does Exelixis have?: Exelixis holds $226.2M in cash and equivalents.
Can Exelixis cover its short-term obligations?: Its current ratio is 3.26 — current assets exceed current liabilities.
Where does Exelixis's balance sheet data come from?: Every line is extracted from Exelixis's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.